Approval · Notice of Compliance 36626 · 2025
LOKELMA: Notice of Compliance 36626
Issued December 22, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36626
- Date
- December 22, 2025
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing site and/or manufacturer involving production of the starting material
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOKELMA | Not yet assigned | — |
Medicinal ingredients
- SODIUM ZIRCONIUM CYCLOSILICATE 5 G per SACHET
- SODIUM ZIRCONIUM CYCLOSILICATE 10 G per SACHET